Publications found:
340
Sort by:
Anticoagulants Market Report by Drug Class (Novel Oral Anticoagulants (NOACs), Heparin and Low Molecular Weight Heparin (LMWH), Vitamin K Antagonist, and Others), Route of Administration (Oral Anticoagulant, Injectable Anticoagulant), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores, and Others), Application (Atrial Fibrillation and Heart Attack, Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Others), and Region 2026-2034
US$ 3,999.00
The global anticoagulants market size reached USD 48.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 97.7 Billion by 2034, exhibiting a growth rate (CAGR) of 7.80% duri...
June 2026
148 pages
Clot Buster Drugs Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Type (Fibrin Specific Drugs {Tissue Plasminogen Activator, Reteplase, Tenecteplase, Others} v/s Non-Fibrin Specific Drugs {Urokinase, Streptokinase, Plasminogen Activating Complex}), By Application (Myocardial Infarction, Pulmonary Embolism, Deep Vein Thrombosis, Acute Ischemic Strokes, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Clot Buster Drugs Market is projected to experience robust growth, expanding from a valuation of USD 35.72 Billion in 2025 to USD 55.78 Billion by 2031, reflecting a compound annual growth...
May 2026
185 pages
Atrial Fibrillation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Pharmacological Treatment (Anti-arrhythmic Drugs), Non-Pharmacological Treatment(Catheter Ablation, Maze Surgery, Electric Cardioversion), By End-use (Hospital, Specialty Clinics, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Atrial Fibrillation Market is poised for significant growth, projected to expand from USD 22.61 Billion in 2025 to USD 35.34 Billion by 2031, achieving a CAGR of 7.73%. This market encompas...
May 2026
185 pages
Lipid Regulators Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type {Statins (Branded statins, Statin combinations, and Generic statins), and Non-statins (Fibric-acid derivatives, Bile-acid Sequestrants, Nicotinic Acid Derivatives, and Other New Products)}, By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Lipid Regulators Market is projected to expand from USD 7.89 Billion in 2025 to USD 11.14 Billion by 2031, reflecting a compound annual growth rate of 5.92%. Lipid regulators function as ph...
May 2026
180 pages
Hypercholesterolemia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Genetic Hypercholesterolemia, Acquired Hypercholesterolemia), By Treatment Type (Statins, PCSK9 Inhibitors, Ezetimibe, Bile Acid Sequestrants, Niacin, Bempedoic Acid, Others), By End User (Hospitals, Specialty Cardiac Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Hypercholesterolemia Treatment Market is projected to expand significantly, rising from USD 21.13 Million in 2025 to USD 33.51 Million by 2031, demonstrating a robust 7.99% CAGR. This growt...
May 2026
182 pages
Wolff Parkinson white syndrome Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Type A, Type B), By Diagnosis (Electrocardiogram (ECG), Electrophysiological Testing, Other Diagnosis), By Treatment (Drugs, Cardioversion, Radiofrequency Catheter Ablation, Surgery, Artificial Pacemaker, Other Treatments), By End User (Hospitals And Clinics, Academic and Research Institutes, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Wolff Parkinson White syndrome Market is projected to expand from USD 1.62 Billion in 2025 to USD 2.28 Billion by 2031, registering a CAGR of 5.86%. Wolff-Parkinson-White (WPW) syndrome, a...
May 2026
185 pages
Amlodipine Besylate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Hypertension, Chronic Stable Angina, Vasospastic Angina, Coronary Artery Disease, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global Amlodipine Besylate market is projected to expand from USD 470.57 million in 2025 to USD 618.81 million by 2031, demonstrating a compound annual growth rate (CAGR) of 4.67%. Amlodipine Besy...
May 2026
182 pages
Homozygous Familial Hypercholesterolemia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Statins, Cholesterol Absorption Inhibitors, PCSK9 Inhibitors, MTP Inhibitors, ANGPTL3 Inhibitors), By Route of Administration (Oral, Parenteral, Nasal), By Technology (CRISPR-Cas9, RNA Interference, Nanoparticle-Based Therapies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Homozygous Familial Hypercholesterolemia (HoFH) Market is projected to expand from USD 94.78 Million in 2025 to USD 111.01 Million by 2031, demonstrating a Compound Annual Growth Rate (CAGR...
May 2026
185 pages
Metoprolol Succinate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Hypertension, Chronic Heart Failure, Angina Pectoris, Arrhythmias, Anxiety, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for Metoprolol Succinate, a beta1-selective adrenoceptor blocker used to manage hypertension, angina pectoris, and chronic heart failure by regulating heart rate and cardiac output,...
May 2026
185 pages
Simvastatin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Hyperlipidemia, Coronary Heart Disease, Diabetes-Related Dyslipidemia, Stroke, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Simvastatin Market is projected to grow from USD 150.19 Million in 2025 to USD 237.14 Million by 2031, achieving a 7.91% CAGR. Simvastatin, a widely prescribed HMG-CoA reductase inhibitor,...
May 2026
177 pages
Takotsubo Syndrome Therapeutic Market Forecasts to 2034 – Global Analysis By Product Type (Anticoagulants, Beta-Blockers, Aldosterone Receptor Blockers, Statins, Diuretics, Angiotensin-Converting Enzyme (ACE) Inhibitors, Dual Antiplatelet Therapy (DAPT) and Other Product Types), Diagnosis, Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Takotsubo Syndrome Therapeutic Market is accounted for $0.52 billion in 2026 and is expected to reach $0.99 billion by 2034 growing at a CAGR of 8.3% during th...
May 2026
200 pages
Global Anti-ANGPTL3 Antibody Drugs Market Growth 2026-2032
US$ 3,660.00
The global Anti-ANGPTL3 Antibody Drugs market size is predicted to grow from US$ 145 million in 2025 to US$ 295 million in 2032; it is expected to grow at a CAGR of 10.0% from 2026 to 2032. In 2025, g...
May 2026
84 pages
